Literature DB >> 20467897

Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.

Juanda L Hartono1, Choon-Seng Qua, Khean-Lee Goh.   

Abstract

AIMS: To compare the esophageal sensitivity to acid and saline in patients with symptomatic and asymptomatic erosive reflux disease (ERD), non-erosive reflux disease (NERD) and controls, and to assess the response to proton-pump inhibitors in patients with symptomatic ERD and NERD.
METHODOLOGY: Patients with GERD and a control group of healthy asymptomatic volunteers were recruited. All subjects underwent esophagogastroduodenoscopy and the acid-saline perfusion test. Symptomatic ERD and NERD patients were given rabeprazole 20 mg twice daily for 2 weeks and their response to treatment assessed.
RESULTS: A total of 105 subjects were recruited: ERD=37 (symptomatic=24, asymptomatic=13), NERD=34 and controls=34. During saline perfusion, only the NERD group recorded a significantly higher sensitivity score compared to controls (2.74±7.28 vs. 0) (p=0.035). During acid perfusion, symptomatic ERD (15.42±13.42) and NERD (16.71±15.04) had significantly higher scores versus controls and asymptomatic ERD patients (both p<0.001). The mean %∆ reflux symptom score following treatment was significantly higher in symptomatic ERD patients compared to NERD patients (89.08±21.67 vs. 58.53±32.54; p<0.001).
CONCLUSIONS: Patients with NERD were a generally hypersensitive group while asymptomatic ERD patients represent a hyposensitive group of patients which merits further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20467897     DOI: 10.1007/s10620-010-1275-5

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Lack of association between esophageal acid sensitivity detected by prolonged pH monitoring and Bernstein testing.

Authors:  Barbara Jung; Joseph Steinbach; Cheryl Beaumont; Ravinder K Mittal
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

2.  Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study.

Authors:  J Ronkainen; P Aro; T Storskrubb; T Lind; E Bolling-Sternevald; O Junghard; N J Talley; L Agreus
Journal:  Aliment Pharmacol Ther       Date:  2006-06-15       Impact factor: 8.171

3.  Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease.

Authors:  J L Smith; A R Opekun; E Larkai; D Y Graham
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

4.  Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.

Authors:  T O Kiljander; E R Salomaa; E K Hietanen; E O Terho
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

5.  Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole.

Authors:  T O Kiljander; E R Salomaa; E K Hietanen; E O Terho
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 6.  Role of the gastric refluxate in gastroesophageal reflux disease: acid, weak acid and bile.

Authors:  Joel E Richter
Journal:  Am J Med Sci       Date:  2009-08       Impact factor: 2.378

7.  Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases.

Authors:  H Miwa; T Minoo; M Hojo; R Yaginuma; A Nagahara; M Kawabe; A Ohkawa; D Asaoka; A Kurosawa; T Ohkusa; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2004-07       Impact factor: 8.171

8.  Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.

Authors:  T L Venables; R D Newland; A C Patel; J Hole; C Wilcock; M L Turbitt
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

Review 9.  Epidemiology of non-erosive reflux disease.

Authors:  Hashem B El-Serag
Journal:  Digestion       Date:  2008-10-02       Impact factor: 3.216

10.  Impaired visceral sensitivity to acid reflux in patients with Barrett's esophagus. The role of esophageal motility*.

Authors:  P J Byrne; E D Mulligan; J O'Riordan; P W N Keeling; J V Reynolds
Journal:  Dis Esophagus       Date:  2003       Impact factor: 3.429

View more
  6 in total

1.  Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.

Authors:  Vittorio Bresadola; Gian Luigi Adani; Francesco Londero; Cosimo Alex Leo; Vittorio Cherchi; Dario Lorenzin; Anna Rossetto; Gianmatteo Vit; Umberto Baccarani; Giovanni Terrosu; Dino De Anna
Journal:  World J Gastrointest Pathophysiol       Date:  2011-06-15

2.  Effect of age and correlation between esophageal visceral chemosensitivity and mechanosensitivity in healthy Japanese subjects.

Authors:  Takahisa Yamasaki; Tadayuki Oshima; Toshihiko Tomita; Takashi Kondo; Fumihiko Toyoshima; Jun Sakurai; Hirokazu Fukui; Takayuki Matsumoto; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

Review 3.  Refractory gastroesophageal reflux disease.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-09-30

Review 4.  Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.

Authors:  A Pali S Hungin; Michael Molloy-Bland; Carmelo Scarpignato
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

5.  Extra-esophageal symptoms in individuals with and without erosive esophagitis: a case-control study in Albania.

Authors:  Edite Sadiku; Eqerem Hasani; Indrit Këlliçi; Iris Mone; Fatjona Kraja; Bledar Kraja; Genc Burazeri
Journal:  BMC Gastroenterol       Date:  2021-02-16       Impact factor: 3.067

Review 6.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.

Authors:  Katsuhiko Iwakiri; Yasuhiro Fujiwara; Noriaki Manabe; Eikichi Ihara; Shiko Kuribayashi; Junichi Akiyama; Takashi Kondo; Hiroshi Yamashita; Norihisa Ishimura; Yuichi Kitasako; Katsunori Iijima; Tomoyuki Koike; Nobuo Omura; Tsutomu Nomura; Osamu Kawamura; Shuichi Ohara; Soji Ozawa; Yoshikazu Kinoshita; Satoshi Mochida; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2022-02-28       Impact factor: 7.527

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.